Sunitinib treatment of renal adjuvant cancer (S-TRAC): A randomized, double-blind, phase III study of sunitinib vs. placebo in subjects at high risk of recurrent renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Ravaud, A.; Motzer, R. J.; Pandha, H.; Staehler, M.; George, D. J.; Pantuck, A.; Patel, A.; Gerletti, P.; Chen, L.; Patard, J. |
| Abstract Title: | Sunitinib treatment of renal adjuvant cancer (S-TRAC): A randomized, double-blind, phase III study of sunitinib vs. placebo in subjects at high risk of recurrent renal cell carcinoma (RCC) |
| Meeting Title: | 37th Congress of the European Society for Medical Oncology (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 23 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2012 Sep 28-Oct 2 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2012-09-01 |
| Start Page: | ix292 |
| End Page: | ix293 |
| Language: | English |
| ACCESSION: | WOS:000309409001370 |
| PROVIDER: | wos |
| PUBMED: | 23012731 |
| DOI: | 10.1093/annonc/mds399 |
| Notes: | Meeting Abstract: 889TiP -- "Source: Wos" |
